What are the side effects of Fostamatinib?

Fostamatinib (Fostamatinib) is a drug used to treat chronic immune thrombocytopenia (ITP) that has had an inadequate response to previous treatment. It is mainly suitable for adult patients. In clinical trials, fotantinib has shown certain efficacy, but it is also accompanied by a variety of side effects.

The most common side effects include diarrhea, which may interfere with a patient's daily life and diet, leading to dehydration and malnutrition. High blood pressure is also a common side effect, so patients need to monitor their blood pressure regularly during treatment to prevent cardiovascular problems. In addition, nausea is another common symptom, which may sometimes be accompanied by vomiting, affecting the patient's appetite and eating.

Respiratory tract infections also increased in patients treated with fotantinib due to the drug's possible effects on the immune system, making patients more susceptible to infections. Dizziness and fatigue are symptoms reported by many patients and may interfere with their daily activities and productivity. Elevated liver enzymes are another area of u200bu200bconcern, and patients need regular liver function monitoring during medication.

Although side effects such as rash, abdominal pain, and chest pain are relatively rare, if they occur, patients should consult their doctor promptly. In addition, a decrease in white blood cell count is one of the possible problems with fotantinib, which may make patients more susceptible to infections.

In some cases, serious adverse reactions such as dyspnea and significant hypertension have also been reported, requiring special attention. In addition, symptoms such as neutropenia, joint pain, kidney stones, limb pain, toothache, syncope, and hypoxia need to be closely monitored. When these serious side effects occur, patients should seek medical help immediately and evaluate with their physician whether adjustments to their treatment plan are needed.

Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=21149cc3-049b-43e2-b141-c9499160556c